<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>How Did the Flu-Shot Shortage Become a Surplus?</title><link>http://articles.mercola.com/sites/articles/archive/2005/01/26/flu-shot-surplus.aspx</link><description>After months of talk of a flu-shot shortage, it appears the shortage has turned into a surplus. Many states already have enough flu vaccine to meet demand, yet Aventis Pasteur, the primary supplier of flu-shot vaccines to the United States, has 3.3 million</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>